Literature DB >> 21055222

[Ewing's sarcoma of bone:treatment results and prognostic factors].

Jie Zang1, Wei Guo, Rong-li Yang, Xiao-dong Tang, Tao Ji.   

Abstract

OBJECTIVE: To determine the prognostic factors from the view of clinic and pathology.
METHODS: A retrospective analysis was performed on a data set of 78 patients with Ewing's sarcoma treated at Peking University People's Hospital Musculoskeletal tumor center between July 1998 and July 2007. Five-year overall survival (OS), recurrence rate and prognostic factors were analyzed in this study. Univariate and multivariate analysis were performed to determine the prognostic factors for OS.
RESULTS: Fifty-three cases were followed up, follow-up time ranged from 8.0 to 101.0 months (median 37.6 months). The 5-year overall survival rate and local recurrence rate were 33.7% and 20.8% respectively. Univariate showed age < 20 years, metastases free at diagnosis, tumor located at extremities, tumor size < 10 cm, adequate surgical margin had better survival rate (all P < 0.05). Multivariate analysis demonstrated that metastases at diagnosis, primary site and tumor size were independent prognostic factors for OS.
CONCLUSION: The independent prognostic factors Ewing's sarcoma are metastases at diagnosis, primary site, tumor size.

Entities:  

Mesh:

Year:  2010        PMID: 21055222

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  2 in total

1.  Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?

Authors:  Elisabetta Pennacchioli; Giulio Tosti; Massimo Barberis; Tommaso M De Pas; Francesco Verrecchia; Claudia Menicanti; Alessandro Testori; Giovanni Mazzarol
Journal:  Clin Exp Metastasis       Date:  2012-06-15       Impact factor: 5.150

2.  Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan.

Authors:  Chih-Ying Lee; Chueh-Chuan Yen; Hsiu-Ju Yen; Cheng-Ying Shiau; Ta-Chung Chao; Po-Kuei Wu; Cheng-Fong Chen; Paul Chih-Hsueh Chen; Hung-Ta Hondar Wu; Hong-Jen Chiou; Chao-Chun Chen; Giun-Yi Hung; Wei-Ming Chen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.